Maria Prange-Barczynska

Maria Prange-Barczynska

Auto-generated profile, based on publicly available information

Maria Prange-Barczynska

Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Cell Reports
Verified
Journal Article
Open access
PWPeter Wing
Peter Wing
TKThomas P. Keeley
Thomas P. Keeley
XZXiaodong Zhuang
Xiaodong Zhuang
JLJeffrey Y. Lee
Jeffrey Y. Lee
MPMaria Prange-Barczynska
Maria Prange-Barczynska
JMJane Mckeating
Jane Mckeating
COVID-19, caused by the novel coronavirus SARS-CoV-2, is a global health issue with more than 2 million fatalities to date. Viral replication is shaped by the cellular microenvironment, and one important factor to consider is oxygen tension, in which hypoxia inducible factor (HIF) regulates transcriptional responses to hypoxia. SARS-CoV-2 primarily infects cells of the respiratory tract, entering via its spike glycoprotein binding to angiotensin-converting enzyme 2 (ACE2). We demonstrate that hypoxia and the HIF prolyl hydroxylase inhibitor Roxadustat reduce ACE2 expression and inhibit SARS-CoV-2 entry and replication in lung epithelial cells via an HIF-1α-dependent pathway. Hypoxia and Roxadustat inhibit SARS-CoV-2 RNA replication, showing that post-entry steps in the viral life cycle are oxygen sensitive. This study highlights the importance of HIF signaling in regulating multiple aspects of SARS-CoV-2 infection and raises the potential use of HIF prolyl hydroxylase inhibitors in the prevention or treatment of COVID-19.

27 October 2022 in Endocrine Abstracts
Verified
Journal Article
Open access
LELuise Eckardt
Luise Eckardt
MPMaria Prange-Barczynska
Maria Prange-Barczynska
EHEmma J Hodson
Emma J Hodson
JFJames W Fielding
James W Fielding
XCXiaotong Cheng
Xiaotong Cheng
TBTammie Bishop
Tammie Bishop
Endocrine-Related Cancer, 2021, 28(12): 757-772 (DOI: https://doi.org/10.1530/ERC-21-0211)